Berkeley Institute International


Clinical center and research group offering a proprietary immuno-chemotherapy protocol designed to preserve patient immune function and reduce conventional chemotherapy side effects. Operates multiple international clinics trained to follow standardized treatment protocols, publishes case-series outcomes, and provides multidisciplinary supportive care and clinician training.

Industries

biotechnology
health-care
medical
therapeutics

Nr. of Employees

small (1-50)

Berkeley Institute International

2855 Telegraph Avenue, Suite 302, Berkeley, CA 94705


Products

SEF Chemotherapy® (Side Effect-Free Chemotherapy)

A cancer treatment that delivers chemotherapy without the typical side effects, preserving the patient's immune system.

SEF Immuno-Chemotherapy

A therapy combining chemotherapy with immune system support to treat cancer without the toxicity of conventional chemotherapy.

Holistic Physical and Emotional Care

Support services addressing the physical, mental, and emotional needs of cancer patients during treatment.

Cancer Support Groups

Facilitated groups offering emotional, social, and educational support to cancer patients, survivors, and caregivers.


Services

Provision of a therapy protocol intended to treat cancer while minimizing conventional chemotherapy side effects and preserving immune function.

Training program for physicians and scientists in the standardized delivery of the proprietary therapy, including multi-clinic protocol implementation.

Emotional, social, and practical support services including support groups, nutrition, and counseling provided alongside clinical treatment.

Expertise Areas

  • Immuno-oncology protocol development
  • Outpatient oncology treatment delivery
  • Clinical protocol standardization and clinician training
  • Multidisciplinary supportive care and survivorship
  • Show More (2)

Key Technologies

  • Immuno-chemotherapy methods
  • Outpatient infusion therapy
  • Clinical imaging (CT, MRI, ultrasound) for response monitoring
  • Clinical case-series documentation and reporting
  • Show More (1)

News & Updates

Short broadcast segment covering publication of multiple years of case studies related to the institute's therapy.

Claim that all patients treated with the institute's therapy in 2006 went into remission and remained cancer-free without typical chemotherapy toxicity.

Operates clinics following standardized protocols in three countries.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.